Denmark’s HTA evolution
New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have prompted GlobalData to take the…
New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have prompted GlobalData to take the…
The mid-year period marks a significant phase for horizon scanning activities that map the regulatory approval progress of innovative medicines…
The EU’s “Union list of critical medicines” stole many pharma-related headlines this week. Its publication is undoubtedly significant, but the…
The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. The…
While the threat of high inflation is receding, its second-round effects may not quickly abate. Pharma may have to navigate…
The European Union (EU) is on the cusp of approving clearer rules governing the joint procurement of medicines and medical…
Last year saw signs that the tide is beginning to turn for the approval of innovative Alzheimer’s disease (AD) medicines,…
n an unusually pronounced trend, the IHS Markit Purchasing Managers Index (PMI)(tm) report for August reveals the global pharmaceutical and…
The innovative pharmaceutical industry has emerged shaken following last week's compromise-driven agreement on joint scientific health technology assessments in the…
In the years to come, Europe is likely to reach an inflection point when it comes to which countries widen…